{"slideshow_credits": null, "snippet": "The New York Stem Cell Foundation and Research!America discuss the problem of developing drugs that help only a relative few patients.", "abstract": null, "section_name": "Opinion", "print_page": "26", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/06/19/opinion/developing-drugs-for-rare-diseases.html", "lead_paragraph": "The New York Stem Cell Foundation and Research!America discuss the problem of developing drugs that help only a relative few patients.", "headline": {"main": "Developing Drugs for Rare Diseases", "print_headline": "Developing Drugs for Rare Diseases", "content_kicker": "Letters", "kicker": "Letters"}, "_id": "51c0ff8d7e0d9c0839d294be", "word_count": "464", "multimedia": [], "pub_date": "2013-06-19T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Stem Cells", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Research", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}